These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 6120243)

  • 1. Propranolol in the ischaemic, reperfused, working rat heart: association between beta-adrenergic blocking activity and protective effect.
    Manning AS; Keogh JM; Coltart DJ; Hearse DJ
    J Mol Cell Cardiol; 1981 Dec; 13(12):1077-80. PubMed ID: 6120243
    [No Abstract]   [Full Text] [Related]  

  • 2. Propranolol in ischaemic-reperfused working rat heart: dissociation of beta-adrenergic blocking and protective effect.
    Arnim TV; Welman E
    J Mol Cell Cardiol; 1981 May; 13(5):521-4. PubMed ID: 7265259
    [No Abstract]   [Full Text] [Related]  

  • 3. Some cardiac metabolic and haemodynamic alterations due to adrenergic beta-receptor blockade.
    Szekeres L; Udvary E; Papp JG
    Acta Biol Med Ger; 1972; 28(6):1031-9. PubMed ID: 4404698
    [No Abstract]   [Full Text] [Related]  

  • 4. Preservation of membrane phospholipids by propranolol, pindolol, and metoprolol: a novel mechanism of action of beta-blockers.
    Liu XK; Engelman RM; Agrawal HR; Das DK
    J Mol Cell Cardiol; 1991 Oct; 23(10):1091-100. PubMed ID: 1684206
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of nipradilol on myocardial energy metabolism in the dog ischaemic heart.
    Hayase N; Chiba K; Ichihara K; Inagaki S; Abiko Y
    J Pharm Pharmacol; 1990 Jun; 42(6):419-22. PubMed ID: 1979622
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Beta adrenergic blockade on intramyocardial distribution of coronary blood flow.
    Gross GJ; Winbury MM
    J Pharmacol Exp Ther; 1973 Dec; 187(3):451-64. PubMed ID: 4149128
    [No Abstract]   [Full Text] [Related]  

  • 7. Effect of a coronary vasodilating substance, carbocromen, on the coronary blood flow under hypoxia and administration of adrenergic blocking agents.
    Koyama T; Nakagawa K; Marutani Y
    Arzneimittelforschung; 1972 Mar; 22(3):502-7. PubMed ID: 4402602
    [No Abstract]   [Full Text] [Related]  

  • 8. Effects of beta-adrenoreceptor blockade and nitroglycerin on myocardial oxygenation.
    Winbury MM; Weiss HR; Howe BB
    Eur J Pharmacol; 1971; 16(3):271-7. PubMed ID: 4399875
    [No Abstract]   [Full Text] [Related]  

  • 9. The effect of beta-adrenergic blockade on coronary blood flow in the homografted canine heart.
    Boake WC; Folts JD
    Arch Int Pharmacodyn Ther; 1971 Jul; 192(1):96-104. PubMed ID: 4398413
    [No Abstract]   [Full Text] [Related]  

  • 10. The effect of alpha- and beta-adrenoceptor antagonist agents on reperfusion ventricular fibrillation and metabolic status in the isolated perfused rat heart.
    Thandroyen FT; Worthington MG; Higginson LM; Opie LH
    J Am Coll Cardiol; 1983 Apr; 1(4):1056-66. PubMed ID: 6131912
    [No Abstract]   [Full Text] [Related]  

  • 11. Haemodynamic and coronary vascular responses after beta-adrenoceptor blockade in the anaesthetised dog: a comparison of tolamolol with practolol and propranolol.
    Adam KR; Boyles SM
    Eur J Pharmacol; 1974 Apr; 26(1):96-107. PubMed ID: 4151643
    [No Abstract]   [Full Text] [Related]  

  • 12. Treadmill exercise in dogs under -adrenergic blockade: adaptation of coronary and systemic hemodynamics.
    Bassenge E; Kucharczyk M; Holtz J; Stoian D
    Pflugers Arch; 1972; 332(1):40-55. PubMed ID: 4401667
    [No Abstract]   [Full Text] [Related]  

  • 13. Beta-blockade in the ischemic reperfused working rabbit heart: dissociation of beta-adrenergic blocking and protective effects.
    Lu HR; Vandeplassche G; Wouters L; Borgers M
    Arch Int Pharmacodyn Ther; 1989; 301():165-81. PubMed ID: 2576193
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of beta-blockade on coronary and systemic circulation in dogs at rest and during adaptation to exercise.
    Ehrlich W; Schrijen FV; Krausman DT; Caldini P; Brady JV
    Arch Int Pharmacodyn Ther; 1973 Aug; 204(2):213-27. PubMed ID: 4147879
    [No Abstract]   [Full Text] [Related]  

  • 15. Adrenoceptor-blocking activity and cardiohemodynamic effects of carvedilol in animals.
    Kawada T; Ishibashi T; Nakazawa M; Satoh S; Imai S
    J Cardiovasc Pharmacol; 1990 Jul; 16(1):147-53. PubMed ID: 1696657
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardiovascular beta-adrenergic receptor blocking activities of 1-(7-indenyloxy)-3-isopropyl-aminopropane-2-ol hydrochloride (YB-2) and its optical isomers.
    Kato H; Noguchi Y; Nakao K; Takagi K
    Jpn J Pharmacol; 1974 Apr; 24(2):261-70. PubMed ID: 4152803
    [No Abstract]   [Full Text] [Related]  

  • 17. Influence of carvedilol and propranolol on coronary blood flow.
    Sievert H; Frey G; Schräder R; Schmidt T; van der Does R; Kaltenbach M; Kober G
    Eur J Clin Pharmacol; 1990; 38 Suppl 2():S122-4. PubMed ID: 1974502
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Haemodynamic changes in patients with coronary heart disease after beta-adrenergic blockade with propranolol.
    Bürgin D
    Int Z Klin Pharmakol Ther Toxikol; 1970 Oct; 4(4):365-70. PubMed ID: 4395489
    [No Abstract]   [Full Text] [Related]  

  • 19. Cardiovascular actions of optical isomers of propranolol.
    Yamamoto J; Sekiya A; Maekawa H; Kato Y
    Jpn J Pharmacol; 1978 Aug; 28(4):627-31. PubMed ID: 32418
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanism of action of beta-blocking drugs in angina pectoris: a review.
    Robinson BF
    Postgrad Med J; 1976; 52 Suppl 4():43-5. PubMed ID: 9630
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.